HJ Science-B (HJ Science Co., Ltd.; HKEX: 06132) has released a multi-faceted corporate action package that will be put to shareholders at an upcoming extraordinary general meeting (EGM).
2026 H-Share Incentive Scheme • The Board has approved a new H-share incentive scheme aimed at long-term employee motivation and alignment. • The scheme will become effective only after: 1) Shareholders pass a special resolution at the EGM; and 2) The Hong Kong Stock Exchange’s Listing Committee approves the listing of any new H-shares to be issued under the plan.
Proposed Change of Company Name • Current name: 華健未來(成都)科技股份有限公司 (HJ Science Co., Ltd.) • Proposed name: 華健未來(成都)生物科技股份有限公司 (HJ Science Co., Ltd.) • Rationale: better alignment with the Group’s biopharmaceutical focus while preserving existing brand equity. • Effectiveness requires shareholder approval and completion of all regulatory filings in the PRC.
Amendments to Articles of Association Subject to EGM approval, the Articles will be updated to: 1) Reflect post-listing changes in registered capital and total issued shares; 2) Incorporate the new company name (if approved); 3) Record the revised number of directors.
Board Changes Appointments (effective upon EGM approval): • Mr. Wang Liyuan, 48 – Veteran in government economic administration, industrial park management and investment; currently chairs Huada (Chongqing) Private Equity Investment Fund Management Co., Ltd. • Mr. Fang Shengshi, 38 – Certified Public Accountant and Certified Tax Agent with extensive audit and investment experience; partner at Ningbo Huaige Health Investment Management Partnership. Holds 15,000 H-shares.
Both nominees will serve as non-executive directors without receiving director fees.
Resignations (effective at EGM close): • Mr. Wang Junfeng, Mr. Zhang Zhiyong and Mr. Du Jiangbo will step down as non-executive directors for personal reasons. They confirmed no disagreements with the Board.
Next Steps A detailed circular—covering the incentive scheme, name change, Articles amendments, director appointments and the EGM notice—will be dispatched to shareholders in due course.
Comments